Windgap Medical

4 articles about Windgap Medical

• Windgap Medical, Inc. Closes Over $39 Million of Series B-1 Investment, More Than Twenty Percent Over Its Initial Goal

  1/20/2022

  Windgap Medical, Inc., a leading specialty pharmaceutical and drug delivery platform company, announced that it has successfully completed its final close with over $39 million of Series B-1 equity financing, led by Taiwania Capital.

• Windgap Medical and University of Minnesota Twin Cities Receive $3.2 Million NIH Grant to Develop Cyanide Antidote Autoinjector

  1/15/2020

  Under the grant, researchers from the University's Center for Drug Design, College of Pharmacy, and Massachusetts-based pharmaceutical company Windgap Medical are collaborating to design an autoinjector.

• Windgap Medical Announces Strategic Investment from Molex Ventures

  1/24/2019

  Windgap Medical, Inc. announced that it has finalized a deal to enable a strategic investment from Molex Ventures, LLC, a subsidiary of Koch Industries.

• Windgap Medical -- Making Progress Toward An Alternative To The EpiPen

  2/10/2016